Type 2 diabetes and hepatocellular carcinoma: A case-control study in patients with chronic hepatitis B
International Journal of Cancer, 04/27/2012Li Q et al.
Type 2 diabetes is independently associated with the increased risk of hepatocellular carcinoma (HCC) in female chronic hepatitis B (CHB) patients. Female CHB patients with Type 2 diabetes are of a high HCC risk population and should be considered for HCC close surveillance program.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.